Noninvasive prenatal chromosomal aneuploidy detection using plasma cell-free nucleic acid

References

• Summers AM, Farrell SA, Huang T, Meier C, Wyatt PR. Maternal serum screening in Ontario using the triple marker test. J. Med. Screen.10(3), 107–111 (2003).
   PubMedGoogle Scholar
• Meier C, Huang T, Wyatt PR, Summers AM. Accuracy of trisomy 18 screening using the second-trimester triple test. Prenat. Diagn.23(6), 443–446 (2003).
   PubMedGoogle Scholar
• Summers AM, Huang T, Meier C, Wyatt PR. The implications of a false positive second-trimester serum screen for Down syndrome. Obstet. Gynecol.101(6), 1301–1306 (2003).
   PubMedGoogle Scholar
• Wapner R, Thom E, Simpson JL et al. First-trimester screening for trisomies 21 and 18. N. Engl. J. Med.349(15), 1405–1413 (2003).
   PubMed Web of Science ®Google Scholar
• Malone FD, Canick JA, Ball RH et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. N. Engl. J. Med.353(19), 2001–2011 (2005).
   PubMed Web of Science ®Google Scholar
• Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet. Gynecol.110(3), 687–694 (2007).
   PubMed Web of Science ®Google Scholar
• Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn. Ther.27(1), 1–7 (2010).
   PubMed Web of Science ®Google Scholar
• Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet1(8493), 1287–1293 (1986).
   PubMed Web of Science ®Google Scholar
• Odibo AO, Gray DL, Dicke JM, Stamilio DM, Macones GA, Crane JP. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center’s 16-year experience. Obstet. Gynecol.111(3), 589–595 (2008).
   PubMed Web of Science ®Google Scholar
• Hewison J, Nixon J, Fountain J et al. A randomised trial of two methods of issuing prenatal test results: the ARIA (Amniocentesis Results: Investigation of Anxiety) trial. BJOG114(4), 462–468 (2007).
   PubMed Web of Science ®Google Scholar
• Hewison J, Nixon J, Fountain J et al. Amniocentesis results: investigation of anxiety. The ARIA trial. Health Technol. Assess.10(50), iii, ix–x, 1–78 (2006).
   Google Scholar
• Hertling-Schaal E, Perrotin F, de Poncheville L, Lansac J, Body G. Maternal anxiety induced by prenatal diagnostic techniques: detection and management. Gynecol. Obstet. Fertil.29(6), 440–446 (2001).
   PubMedGoogle Scholar
• Bianchi DW, Simpson JL, Jackson LG et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat. Diagn.22(7), 609–615 (2002).
   PubMed Web of Science ®Google Scholar
• Mandel P, Metais P. [Not Available.]. C. R. Seances Soc. Biol. Fil.142(3–4), 241–243 (1948).
   PubMedGoogle Scholar
• Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res.37(3), 646–650 (1977).
   PubMed Web of Science ®Google Scholar
• Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology46(5), 318–322 (1989).
   PubMed Web of Science ®Google Scholar
• Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ, Yao SL. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol. Biomarkers Prev.3(1), 67–71 (1994).
   PubMed Web of Science ®Google Scholar
• Vasioukhin V, Anker P, Maurice P, Lyautey J, Lederrey C, Stroun M. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br. J. Haematol.86(4), 774–779 (1994).
   PubMed Web of Science ®Google Scholar
• Lo YM, Corbetta N, Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet350(9076), 485–487 (1997).
   PubMed Web of Science ®Google Scholar
• Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl Acad. Sci. USA105(42), 16266–16271 (2008).
   PubMed Web of Science ®Google Scholar
• Lo YM, Lun FM, Chan KC et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc. Natl Acad. Sci. USA104(32), 13116–13121 (2007).
   PubMed Web of Science ®Google Scholar
• Lun FM, Chiu RW, Allen Chan KC, Yeung Leung T, Kin Lau T, Dennis Lo YM. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin. Chem.54(10), 1664–1672 (2008).
   PubMed Web of Science ®Google Scholar
• Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet.64(1), 218–224 (1999).
   PubMed Web of Science ®Google Scholar
• Lo YM, Lau TK, Zhang J et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin. Chem.45(10), 1747–1751 (1999).
   PubMed Web of Science ®Google Scholar
• Lo YM, Leung TN, Tein MS et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem.45(2), 184–188 (1999).
   PubMed Web of Science ®Google Scholar
• Illanes S, Parra M, Serra R et al. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat. Diagn.29(12), 1118–1122 (2009).
   PubMed Web of Science ®Google Scholar
• Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin. Chem.46(11), 1832–1834 (2000).
   PubMed Web of Science ®Google Scholar
• Chiu RW, Lui WB, Cheung MC et al. Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. Clin. Chem.52(2), 313–316 (2006).
   PubMed Web of Science ®Google Scholar
• Ng EK, Tsui NB, Lam NY et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem.48(8), 1212–1217 (2002).
   PubMed Web of Science ®Google Scholar
• Hasselmann DO, Rappl G, Tilgen W, Reinhold U. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin. Chem.47(8), 1488–1489 (2001).
   PubMed Web of Science ®Google Scholar
• Gupta AK, Holzgreve W, Huppertz B, Malek A, Schneider H, Hahn S. Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro. Clin. Chem.50(11), 2187–2190 (2004).
   PubMed Web of Science ®Google Scholar
• Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. Br. Med. J.336(7648), 816–818 (2008).
   PubMed Web of Science ®Google Scholar
• Faas BH, Beuling EA, Christiaens GC, von dem Borne AE, van der Schoot CE. Detection of fetal RHD-specific sequences in maternal plasma. Lancet352(9135), 1196 (1998).
   PubMed Web of Science ®Google Scholar
• Chiu RW, Chan CW, Zhong XY et al. Fetal rhesus D mRNA is not detectable in maternal plasma. Clin. Chem.51(11), 2210–2211 (2005).
   PubMedGoogle Scholar
• Lo YM. Fetal DNA in maternal plasma: biology and diagnostic applications. Clin. Chem.46(12), 1903–1906 (2000).
   PubMed Web of Science ®Google Scholar
• Lo YM. Fetal RhD genotyping from maternal plasma. Ann. Med.31(5), 308–312 (1999).
   PubMed Web of Science ®Google Scholar
• Lo YM, Hjelm NM, Fidler C et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N. Engl. J. Med.339(24), 1734–1738 (1998).
   PubMed Web of Science ®Google Scholar
• Ding C, Chiu RW, Lau TK et al. MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc. Natl Acad. Sci. USA101(29), 10762–10767 (2004).
   PubMed Web of Science ®Google Scholar
• Li Y, Holzgreve W, DI Naro E, Vitucci A, Hahn S. Cell-free DNA in maternal plasma: is it all a question of size? Ann. N. Y. Acad. Sci.1075, 81–87 (2006).
   PubMed Web of Science ®Google Scholar
• Wood LD, Parsons DW, Jones S et al. The genomic landscapes of human breast and colorectal cancers. Science318(5853), 1108–1113 (2007).
   PubMed Web of Science ®Google Scholar
• Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for b-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA293(7), 843–849 (2005).
   PubMed Web of Science ®Google Scholar
• Tsui NB, Chim SS, Chiu RW et al. Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J. Med. Genet.41(6), 461–467 (2004).
   PubMed Web of Science ®Google Scholar
• Rakyan VK, Down TA, Thorne NP et al. An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res.18(9), 1518–1529 (2008).
   PubMed Web of Science ®Google Scholar
• Lo YM, Tsui NB, Chiu RW et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat. Med.13(2), 218–223 (2007).
   PubMed Web of Science ®Google Scholar
• Tsui NB, Wong BC, Leung TY, Lau TK, Chiu RW, Lo YM. Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasma SERPINB2 mRNA: a feasibility study. Prenat. Diagn.29(11), 1031–1037 (2009).
   PubMedGoogle Scholar
• Chiu RW, Chim SS, Wong IH et al. Hypermethylation of RASSF1A in human and rhesus placentas. Am. J. Pathol.170(3), 941–950 (2007).
   PubMed Web of Science ®Google Scholar
• Chan KC, Ding C, Gerovassili A et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin. Chem.52(12), 2211–2218 (2006).
   PubMed Web of Science ®Google Scholar
• Tsui DW, Chan KC, Chim SS et al. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat. Diagn.27(13), 1212–1218 (2007).
   PubMed Web of Science ®Google Scholar
• Tong YK, Ding C, Chiu RW et al. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin. Chem.52(12), 2194–2202 (2006).
   PubMed Web of Science ®Google Scholar
• Chim SS, Tong YK, Chiu RW et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc. Natl Acad. Sci. USA102(41), 14753–14758 (2005).
   PubMed Web of Science ®Google Scholar
• Chim SS, Jin S, Lee TY et al. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin. Chem.54(3), 500–511 (2008).
   PubMed Web of Science ®Google Scholar
• Papageorgiou EA, Fiegler H, Rakyan V et al. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am. J. Pathol.174(5), 1609–1618 (2009).
   PubMed Web of Science ®Google Scholar
• Old RW, Crea F, Puszyk W, Hulten MA. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod. Biomed. Online15(2), 227–235 (2007).
   PubMed Web of Science ®Google Scholar
• Chu T, Burke B, Bunce K, Surti U, Allen Hogge W, Peters DG. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Prenat. Diagn.29(11), 1020–1030 (2009).
   PubMed Web of Science ®Google Scholar
• Pohl G, Shih Ie M. Principle and applications of digital PCR. Expert Rev. Mol. Diagn.4(1), 41–47 (2004).
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Kinzler KW. Digital PCR. Proc. Natl Acad. Sci. USA96(16), 9236–9241 (1999).
   PubMed Web of Science ®Google Scholar
• Mitra RD, Church GM. In situ localized amplification and contact replication of many individual DNA molecules. Nucleic Acids Res.27(24), e34 (1999).
   Google Scholar
• Diehl F, Li M, He Y, Kinzler KW, Vogelstein B, Dressman D. BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions. Nat. Methods3(7), 551–559 (2006).
   PubMed Web of Science ®Google Scholar
• Li M, Diehl F, Dressman D, Vogelstein B, Kinzler KW. BEAMing up for detection and quantification of rare sequence variants. Nat. Methods3(2), 95–97 (2006).
   PubMed Web of Science ®Google Scholar
• Diehl F, Schmidt K, Durkee KH et al. Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients. Gastroenterology135(2), 489–498 (2008).
   PubMed Web of Science ®Google Scholar
• Fan HC, Blumenfeld YJ, El-Sayed YY, Chueh J, Quake SR. Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy. Am. J. Obstet. Gynecol.200(5), 543.e1–7 (2009).
   PubMed Web of Science ®Google Scholar
• Zhou W, Goodman SN, Galizia G et al. Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet359(9302), 219–225 (2002).
   PubMed Web of Science ®Google Scholar
• Weaver S, Dube S, Mir A et al. Taking qPCR to a higher level: analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution. Methods50(4), 271–276 (2010).
   PubMed Web of Science ®Google Scholar
• White RA 3rd, Blainey PC, Fan HC, Quake SR. Digital PCR provides sensitive and absolute calibration for high throughput sequencing. BMC Genomics10, 116 (2009).
   PubMed Web of Science ®Google Scholar
• Tsui NB, Akolekar R, Chiu RW et al. Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin. Chem.56(1), 73–81 (2010).
   PubMed Web of Science ®Google Scholar
• Ansorge WJ. Next-generation DNA sequencing techniques. Nat. Biotechnol.25(4), 195–203 (2009).
   Google Scholar
• Reis-Filho JS. Next-generation sequencing. Breast Cancer Res.11(Suppl. 3), S12 (2009).
   PubMedGoogle Scholar
• Shendure J, Ji H. Next-generation DNA sequencing. Nat. Biotechnol.26(10), 1135–1145 (2008).
   PubMed Web of Science ®Google Scholar
• Chiu RW, Lo YM. Noninvasive prenatal diagnosis by analysis of fetal DNA in maternal plasma. Methods Mol. Biol.336, 101–109 (2006).
   PubMedGoogle Scholar
• Chiu RW, Sun H, Akolekar R et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin. Chem.56(3), 459–463 (2010).
   PubMed Web of Science ®Google Scholar
• Chu T, Bunce K, Hogge WA, Peters DG. Statistical model for whole genome sequencing and its application to minimally invasive diagnosis of fetal genetic disease. Bioinformatics25(10), 1244–1250 (2009).
   PubMedGoogle Scholar
• Chiu RW, Chan KC, Gao Y et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc. Natl Acad. Sci. USA105(51), 20458–20463 (2008).
   PubMed Web of Science ®Google Scholar
• Pushkarev D, Neff NF, Quake SR. Single-molecule sequencing of an individual human genome. Nat. Biotechnol.27(9), 847–852 (2009).
   PubMed Web of Science ®Google Scholar
• Eid J, Fehr A, Gray J et al. Real-time DNA sequencing from single polymerase molecules. Science323(5910), 133–138 (2009).
   PubMed Web of Science ®Google Scholar
• Wolinsky H. The thousand-dollar genome. Genetic brinkmanship or personalized medicine? EMBO Rep.8(10), 900–903 (2007).
   PubMed Web of Science ®Google Scholar